Analysis of FAM155B expression in cancer cell lines using CCLE data demonstrated widespread expression across diverse cancer types, with particularly high levels in gallbladder, leukemia, and lymphoma cell lines (Figure 2C). The gene discussed is NALF2; the disease is leukemia.